Why Ancillare
Because of Our Therapeutic and Medical Expertise
From emerging biotechs to large-scale Phase III clinical trials, our clinical trial supply chain services adapt to meet the unique needs of every trial portfolio. Whether you are a local startup or a global pharmaceutical leader, our dedicated team is here to support you.
With a patient-centric approach, we take full ownership of your supply chain success by ensuring timely trial launches without regulatory delays related to ancillary supplies. This means patients receive seamless support, sponsors’ goals are achieved, and you realize significant cost savings.
Our therapeutically diverse portfolio spans extensive experience in:
- Cardiovascular
- Oncology
- Vaccines
- Endocrine and Metabolic
- Neuroscience
- Ophthalmology
- Women’s Health
This experience allows us to rapidly design and deliver customized supply programs tailored to your trials, accelerating timelines, and overcoming roadblocks.
Because to Research Faster, You Need a Partner That Can Reach Further
Our global footprint serves clinical sites in over 100 countries. Ancillare offers its partners unparalleled access to site networks, ensuring the continous progress of clinical research.
Horsham, PA (USA)
Global Headquarters
Ontario, Canada
Depot
Rio De Janeiro, Brazil
Depot
Mexico City, Mexico
Depot
Brasilia, Brazil
Depot
Amstelveen, Netherlands (Ancillare B.V.)
European Headquarters
United Kingdom
Depot
Belgrade, Serbia
Depot
Turkey
Depot
Tel Aviv, Israel
Depot
South Africa
Depot
India
Depot
Chengdu, China
Depot
Taiwan
Depot
Philippines
Depot
Melbourne, Australia
Depot
Tokyo, Japan
Depot
Seoul, South Korea
Depot
Because of Our Mission
At Ancillare, our mission is to maintain the integrity, quality, and flow of the global Clinical Trial Ancillary Supply Chain (CTASC™) so our partners can focus on their mission to develop innovative therapies for patients.
Because of Our Story
In 2006, Ancillare embarked on an ambitious mission – to create the first-ever business dedicated wholly to perfecting Ancillary Supply Chain Management. Work began when a study sponsor challenged Ancillare to solve a critical inefficiency for a trial’s needed non-drug items. The sponsor’s project teams, devoted to bringing life-changing therapies to market, struggled under the chaos of sourcing and tracking the supplies needed to move trials forward. It was costing millions daily. Ancillare decided to step up and meet the sponsor’s needs, spurred on by the recognition of a clear truth: clinical trials required an unwavering supply chain focus.
Driven by the belief that every trial could be compliant and cost-effective, Ancillare developed groundbreaking services never seen before in the clinical research space, allowing teams to concentrate on what matters most — the patient. Ancillare’s pioneering vision fueled the creation of tailored, managed programs that deliver consistent, reliable supply chains and accelerate trials at lower costs—enabling research to move faster and change patient lives.
Because We are Industry Organization Members
We partner with the leaders and organizations shaping the future of clinical research supply chain management.
Because We Are Led by the Pioneers of the Industry
The Minds Behind Clinical Trial Ancillary Supply Chain (CTASC™)
Ancillare is the full-service ancillary supply partner for Life Sciences companies at every stage, enabling them to conduct clinical research transparently and cost-effectively. As pioneers in clinical trial ancillary supply consulting and management, we arm sponsors with customized, end-to-end supply plans – applying proven strategies born from innovative problem solving.
Leveraging our industry-shaping model, developers of new therapies navigate supply chain complexities, relying on streamlined processes, extensive global buying power, a vast depot network, and proven teams of experts to cut costs and cycle times— ensuring a smooth journey from clinical potential to thriving trials.
Dr. Joanne Santomauro
Co-Founder & Chief Executive Officer
Jonathan Santomauro
CO-FOUNDER & CHIEF STRATEGY OFFICER
Frank Santomauro
CO-FOUNDER & CHIEF COMMERCIAL OFFICER
Because of Our Executive Leadership
Michael Brown
Chief Business Officer
Michael Brown is the Chief Business Officer at Ancillare and is responsible for the overall growth strategy of Commercial Operations, including direct oversight of Business Development and Marketing.
Michael has over 25 years of experience in global business development, client relationships, and clinical trial management innovations within the pharmaceutical and CRO industries. Working closely with other senior leaders, Mike will help drive growth, ensure financial strength, and maintain the organization’s competitive edge.
Michael holds a Bachelor of Business Administration from The Wharton School of the University of Pennsylvania. He also served in the United States Air Force.
Cathy Porretti
CHIEF GLOBAL OPERATIONS OFFICER
Cathy Porretti has contributed to Ancillare’s rapid growth since the company’s inception in 2006, with high leadership and involvement in all ERP and financial operations. She has played a key role in managing and scaling Ancillare’s global operations, having served in a Global Operations Executive Leadership capacity for nearly 30 years.
She is a key strategist among the company’s leadership, developing innovative solutions for the ancillary supply chain worldwide. As a subject matter expert on Ancillare’s global distribution network, Cathy has overseen the company’s expansion into new and emerging markets, leading day-to-day and strategic management of key depots across the globe.
Danielle Frederick
CHIEF CLINICAL OFFICER
Danielle holds a Bachelor of Science in Business Administration from the California Coast University and maintains multiple certifications, including the Executive Leadership Certificate from Cornell University, ASQ Certified Quality Auditor and Certified Manager of Quality and Organizational Excellence.
Barbara Falco
VP, Quality Assurance and Regulatory Compliance
Barbara Falco is an accomplished Senior Executive and Consultant with more than 35 years of success across the pharmaceutical, biotech, and medical device industries. Leveraging extensive experience in pharmaceutical quality assurance her broad areas of expertise include leadership, risk assessment, project management, and brand security.
Throughout her executive career, she has been responsible for business development, creating quality management systems, strategic planning, regulatory strategy and remediation, and managing supplier company relationships. Barbara was responsible for developing company quality management systems, managing the supplier quality program, and interfacing with global regulators to maintain regulatory compliance.
Barbara also has extensive experience managing and auditing suppliers as well as a background working in quality assurance and control in the API industry. She spent over 10 years on the board of directors of the International Pharmaceutical Aerosol Consortium (IPAC-RS) where she served as the chair of the supplier quality working group that developed and published (2006 and 2011) guidelines for orally inhaled and nasal drug product component supplier quality. Barbara continues to serve as a science advisor for IPAC-RS.
Ayshia Armorer, Esq., J.D., CHC
IN-HOUSE COUNSEL & PRIVACY OFFICER
Her legal experience encompasses internal and commercial contract drafting and review, mass torts defense preparation, and medical malpractice. Ayshia has a robust background in healthcare defense, project management, and clinical trial documentation drafting and review. She provides strategic legal advice to management and business development teams, focusing on protecting legal rights and mitigating risk.
Beyond her role at Ancillare, Ayshia is an accomplished educator, teaching MBA-level courses in business law, ethics, labor & employment relations, and entrepreneurship. Previously, she was the Managing Attorney and Principal at her own law firm and spent 15 years as a staff attorney at a major Philadelphia firm, honing her expertise in pharmaceutical defense.
Ayshia holds a Bachelor of Science in Criminal Justice from John Jay College of Criminal Justice, a Juris Doctor from Temple University’s James E. Beasley School of Law, and a Certificate in Healthcare Compliance from Seton Hall Law School.
Interested in Scoping a Project with Ancillare?